Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
41.53%
operating margin TTM
47.86%
revenue TTM
2.22 Billion
revenue per share TTM
49.52$
valuation ratios | |
|---|---|
| pe ratio | 10.94 |
| peg ratio | 1.26 |
| price to book ratio | 2.03 |
| price to sales ratio | 4.56 |
| enterprise value multiple | 9.04 |
| price fair value | 2.03 |
profitability ratios | |
|---|---|
| gross profit margin | 89.24% |
| operating profit margin | 47.86% |
| pretax profit margin | 53.49% |
| net profit margin | 41.53% |
| return on assets | 16.23% |
| return on equity | 20.27% |
| return on capital employed | 20.78% |
liquidity ratio | |
|---|---|
| current ratio | 5.25 |
| quick ratio | 5.03 |
| cash ratio | 2.30 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 186.09 |
| operating cycle | 221.52 |
| days of payables outstanding | 7.07 |
| cash conversion cycle | 214.45 |
| receivables turnover | 10.30 |
| payables turnover | 51.62 |
| inventory turnover | 1.96 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.05 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | 32.10 |
| cash flow to debt ratio | 4.42 |
cash flow ratios | |
|---|---|
| free cash flow per share | 24.17 |
| cash per share | 73.09 |
| operating cash flow per share | 29.69 |
| free cash flow operating cash flow ratio | 0.81 |
| cash flow coverage ratios | 4.42 |
| short term coverage ratios | 4.42 |
| capital expenditure coverage ratio | 5.38 |
Frequently Asked Questions
When was the last time United Therapeutics Corporation (NASDAQ:UTHR) reported earnings?
United Therapeutics Corporation (UTHR) published its most recent earnings results on 30-10-2024.
What is United Therapeutics Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. United Therapeutics Corporation (NASDAQ:UTHR)'s trailing twelve months ROE is 20.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. United Therapeutics Corporation (UTHR) currently has a ROA of 16.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did UTHR's net profit margin stand at?
UTHR reported a profit margin of 41.53% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is UTHR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.25 in the most recent quarter. The quick ratio stood at 5.03, with a Debt/Eq ratio of 0.05.